Catherine Burke, MD

Assistant Professor

Dr. Burke is a practicing hospitalist at UCSF Parnassus and Mt. Zion campuses, where she provides direct care for patients admitted to the general medicine wards and provides medical consultations for patients admitted to surgery and psychiatry services. She also oversees patient care and provides education to Internal Medicine residents and medical students on the general medicine teaching teams. Her clinical interests include the hospitalized experience, bedside communication, Emergency Room triage / hospital flow, and interprofessional / interspecialty dynamics.

In addition to her clinical work, Dr. Burke serves as a lecturer and small group instructor in the School of Medicine, as well as an Admissions Committee member for the medical school and Internal Medicine residency programs at UCSF.

Education
Fellowship, 2021 - Academic Hospital Medicine, University of California, San Francisco
Residency, 2020 - UC Primary Care / General Internal Medicine, University of California, San Francisco
MD, 2017 - Medical School, University of California, San Francisco
BA, 2011 - Sociology, Tufts University
Publications

  1. Sheu L, Burke C, Masters D, O'Sullivan PS. Understanding Clerkship Student Roles in the Context of 21st-Century Healthcare Systems and Curricular Reform. Teaching and learning in medicine 2018. PMID: 29509038


  2. Hurstak E, Rowe C, Turner C, Behar E, Cabugao R, Lemos NP, Burke C, Coffin P. Using medical examiner case narratives to improve opioid overdose surveillance. The International journal on drug policy 2018. PMID: 29353022


  3. Visconti AJ, Santos GM, Lemos NP, Burke C, Coffin PO. Opioid Overdose Deaths in the City and County of San Francisco: Prevalence, Distribution, and Disparities. Volume 92 of Issue 4. 2015. PMID: 26077643


  4. Heselmeyer-Haddad KM, Berroa Garcia LY, Bradley A, Hernandez L, Hu Y, Habermann JK, Dumke C, Thorns C, Perner S, Pestova E, Burke C, Chowdhury SA, Schwartz R, Schäffer AA, Paris PL, Ried T. Single-cell genetic analysis reveals insights into clonal development of prostate cancers and indicates loss of PTEN as a marker of poor prognosis. The American journal of pathology 2014. PMID: 25131421


  5. Paris PL, Weinberg V, Albo G, Roy R, Burke C, Simko J, Carroll P, Collins C. A group of genome-based biomarkers that add to a Kattan nomogram for predicting progression in men with high-risk prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2009. PMID: 20028763